On 11/15/24, Marker Therapeutics Inc (NASDAQ: MRKR) stock suffered a major decline of -12.3%, closing at $3.07. This decline was accompanied by normal trading volume. Relative to the market the stock has been weak over the last nine months and has declined -28.4% during the last week.
Current PriceTarget Research Rating
Marker Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Marker Therapeutics has a very low Appreciation Score of 12 and a very low Power Rating of 10, leading to the Lowest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment